01.27.26 -- Unpacking The EU's Mutual Recognition Agreements For Pharma

Adrulipase spray-dried dispersions were evaluated to create an orally delivered, enteric-protected enzyme. The lead formulation provided the best acid protection, rapid release, and stability.

Uncover how automation can enhance topical drug development — from pre-formulation studies to performance testing — ultimately supporting more efficient, reliable, and patient-friendly therapies.

Successful analytical method transfer is crucial for quality and compliance. Learn best practices for tech transfer, including how gap assessments mitigate common risks and streamline bioprocessing.

Aseptic drug manufacturing is going small. Discover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility.

Experts explore permeation enhancers for drug absorption, PBPK modeling for formulation design, and fast-dissolving orally disintegrating tablets (ODTs) shaping drug development.

Cell and gene therapy has evolved from a niche concept to a booming sector in just five years, with over 1,300 companies and growing momentum in innovation, investment, and regulatory approvals.

Examine how Isothermal Titration Calorimetry precisely analyzes molecular interactions, which provides crucial thermodynamic data to understand physiological processes and develop new strategies.

Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.

Gain insight into how you can simplify mixer selection for a particular capsule-shell formulation by considering the formulation's viscosity and the appropriate level of shear.

A top pharma producer modernized its operations by digitizing paper-based logbooks. Find out how this shift supports compliance and scalability across global manufacturing environments.

This presentation addresses the critical need for high-throughput, reliable analytical development strategies to support expedited Investigational New Drug (IND) applications.

The potency and effectiveness of the ADCs are dependent upon engineered nanoparticles (ENPs), but little is known about the environmental and human health hazards posed by ENPs.

Rapid GMP certification is possible with Annex 1-aligned aseptic workflows that reduce contamination risks. See how advanced automation and isolator technologies help CDMOs meet regulatory demands.

Read about how filling spray-dried powders directly into syringes improves stability, minimizes cold chain reliance, and accelerates administration speeds for critical therapies.

Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.